Peter Schraml
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Renal cell carcinoma treatment 63
- Prostate Cancer Treatment and Research 8
-
- Cancer Genomics and Diagnostics 15
- Cancer, Hypoxia, and Metabolism 13
- Breast Cancer Treatment Studies 12
- Co-authors
- Holger Moch (108 shared papers)Guido Sauter (31 shared papers)Michael Jörg Mihatsch (26 shared papers)Juha Kononen (13 shared papers)Lukas Bubendorf (11 shared papers)Joachim K. H. Torhorst (4 shared papers)Stephen B. Leighton (1 shared paper)Maarit Tuulikki Barlund (1 shared paper)
- Journals
- American Journal Of Pathology (10 papers)Oncogene (10 papers)The Journal of Pathology (8 papers)Modern Pathology (7 papers)International Journal of Cancer (7 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Peter Schraml
166 papers receiving 14k citations
Peter Schraml's Hit Papers
Peers
Comparison fields: 5 of 128
- Cancer Research 2.7k
- Oncology 2.6k
- Pulmonary and Respiratory Medicine 3.6k
- Molecular Biology 3.5k
- Genetics 438
Countries citing papers authored by Peter Schraml
This map shows the geographic impact of Peter Schraml's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schraml with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schraml more than expected).
Fields of papers citing papers by Peter Schraml
This network shows the impact of papers produced by Peter Schraml. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schraml. The network helps show where Peter Schraml may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Schraml, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tissue microarrays for high-throughput molecular profiling of tumor specimens Hit paper breakdown → | 1998 | 3491 |
| 2 | Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Hit paper breakdown → | 1999 | 503 |
| 3 | Tissue microarrays for gene amplification surveys in many different tumor types. | 1999 | 388 |
| 4 | 2017 | 322 | |
| 5 | 1999 | 320 | |
| 6 | 2004 | 301 | |
| 7 | 1999 | 299 | |
| 8 | Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. | 2000 | 281 |
| 9 | 2001 | 272 | |
| 10 | 2001 | 251 | |
| 11 | 2000 | 216 | |
| 12 | 2004 | 205 | |
| 13 | 1998 | 201 | |
| 14 | 2012 | 192 | |
| 15 | 2001 | 187 | |
| 16 | 2004 | 187 | |
| 17 | Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. | 2001 | 165 |
| 18 | 2021 | 163 | |
| 19 | 2016 | 161 | |
| 20 | 2017 | 154 |
About Peter Schraml
Peter Schraml is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Surgery, having authored 167 papers that have together received 14.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (63 papers), Cancer Genomics and Diagnostics (15 papers), Bladder and Urothelial Cancer Treatments (14 papers), Cancer, Hypoxia, and Metabolism (13 papers), Breast Cancer Treatment Studies (12 papers), Prostate Cancer Treatment and Research (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Chromatin Remodeling and Cancer (5 papers). The work is most often cited by research in Cancer Research (2.7k citations), Oncology (2.6k citations), Pulmonary and Respiratory Medicine (3.6k citations), Molecular Biology (3.5k citations) and Genetics (438 citations). Peter Schraml has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Holger Moch, Guido Sauter, Michael Jörg Mihatsch, Juha Kononen, Lukas Bubendorf, Joachim K. H. Torhorst, Stephen B. Leighton, Maarit Tuulikki Barlund, Olli Kallioniemi and Ronald Simon. Their work appears in journals such as American Journal Of Pathology, Oncogene, The Journal of Pathology, Modern Pathology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.